Serous epithelial ovarian cancer
Showing 9976 - 10000 of >10,000
Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta
Recruiting
- Advanced Pancreatic Adenocarcinoma
- +2 more
- Gemcitabine
- +3 more
-
Atlanta, Georgia
- +2 more
Feb 28, 2022
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Fibrolamellar Cancer, FLC, Liver Cancer Trial in New York (Questionnaire)
Recruiting
- Fibrolamellar Cancer
- +2 more
- Questionnaire
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 28, 2022
Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab)
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Beijing, Beijing, ChinaCancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 13, 2022
Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)
Recruiting
- Biliary Tract Cancer
- SMT-NK inj.+Pembrolizumab
- Pembrolizumab
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +2 more
Jun 28, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Efficacy and Safety of Anlotinib for Advanced Non-small Cell
Completed
- NSCLC
-
Wuhan, Hubei, ChinaHubei province
Oct 19, 2022
Human Papilloma Virus Infection, Human Papilloma Virus Integration, Cervical Intraepithelial Neoplasia Trial in Wuhan
Not yet recruiting
- Human Papilloma Virus Infection
- +4 more
- diagnostic cervical conization
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Aug 19, 2022
Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency, Chemo Effect Trial in Nanjing (Docetaxel,
Recruiting
- Hormone Sensitive Metastatic Prostate Cancer
- +3 more
- Docetaxel
- +2 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Jul 13, 2022
Pancreas Cancer Trial in Hong Kong (TAS 102)
Recruiting
- Pancreas Cancer
- TAS 102
-
Hong Kong, Hong KongDepartment of Clinical Oncology, HKU
Jul 13, 2022
Non Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib and Platinum)
Not yet recruiting
- Non Small Cell Lung Cancer
- IBI-322 Plus Lenvatinib and Platinum
-
Changsha, Hunan, ChinaHunan Cancer hospital
Jul 14, 2022
Colorectal Cancer, Healthy Lifestyle, Behavior, Health Trial in Los Angeles (RISE Personalized Self-Managament Training (PSMT),
Not yet recruiting
- Colorectal Cancer
- +3 more
- RISE Personalized Self-Managament Training (PSMT)
- Standardized Self-Managament Training (SSMT)
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 2, 2023
Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,
Not yet recruiting
- Slow-Flow Vascular Malformation
- +17 more
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Aug 7, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
Aug 1, 2023
Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma Trial in Canada, United States (3-Dimensional
Active, not recruiting
- Extensive Stage Small Cell Lung Carcinoma
- Limited Stage Small Cell Lung Carcinoma
- 3-Dimensional Conformal Radiation Therapy
- +4 more
-
Birmingham, Alabama
- +282 more
Nov 1, 2022
New Healthcare Approach Trial in Munich (Intervention)
Not yet recruiting
- New Healthcare Approach
- Intervention
-
Munich, GermanyKlinikum rechts der Isar, Frauenklinik, Technische Universität M
Aug 12, 2022
And Immuno-meDIated Adverse Events in Anti-cancer
Not yet recruiting
- Cancer
- (no location specified)
Jun 26, 2023
Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in Lymph Node
- +3 more
- Antiandrogen Therapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 3, 2022
Prostatic Tumors, Exercise, Castration-resistant Prostate Cancer Trial in Ghent (Exercise)
Completed
- Prostatic Neoplasms
- +3 more
- Exercise
-
Ghent, Oost-Vlaanderen, BelgiumUniversity Hospital ghent
Dec 22, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Active, not recruiting
- Breast Cancer
- Abemaciclib
- +4 more
-
Ijui, Rio Grande Do Sul, Brazil
- +44 more
Aug 8, 2022
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated
Enrolling by invitation
- Cardiotoxicity
- +3 more
- Chemoradiation
-
Birmingham, Alabama
- +6 more
Nov 1, 2022
After Pancreatic Resection for Pancreatic Cancer
Recruiting
- Pancreatic Malignant Neoplasm Primary
-
Verona, ItalyUniversity of Verona Hospital
Nov 1, 2022
Colorectal Cancer, Colorectal Carcinoma Trial in United States (Risk Factor Questionnaire)
Recruiting
- Colorectal Cancer
- Colorectal Carcinoma
- Risk Factor Questionnaire
-
Basking Ridge, New Jersey
- +7 more
Oct 4, 2021
PSA Level Greater Than Two, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in Duarte, South Pasadena (drug, radiation, other)
Active, not recruiting
- PSA Level Greater Than Two
- Stage IV Prostate Adenocarcinoma AJCC v7
- Bicalutamide
- +4 more
-
Duarte, California
- +1 more
Apr 4, 2022